Literature DB >> 2120345

Immune responses during human Schistosoma mansoni. XVII. Recognition by monoclonal anti-idiotypic antibodies of several idiotopes on a monoclonal anti-soluble schistosomal egg antigen antibody and anti-soluble schistosomal egg antigen antibodies from patients with different clinical forms of infection.

M A Montesano1, G L Freeman, G Gazzinelli, D G Colley.   

Abstract

A monoclonal human anti-soluble schistosomal egg Ag(SEA) antibody (E5) that stimulates anti-Id T cells and is idiotypically represented in pools of immunoaffinity-purified human anti-SEA antibodies from chronic, generally asymptomatic, intestinal (INT) patients (AM1 and AM5) was used to raise several monoclonal anti-Id: 1C2, 1C6, 4A8, 4F9, and 2A7. Cross-inhibition between these anti-Id identified distinct idiotopes on E5. Anti-SEA preparations from schistosomiasis patients (AM1, AM5, and others) were tested for their inhibition of the E5/monoclonal anti-Id reactions, in competitive ELISA. In either the E5/4A8 or E5/1C6 ELISA system, anti-SEA from INT (AM1 or AM5) or hepatointestinal (HI) (AM7) patients were able to inhibit these reactions. However, anti-SEA antibodies from acute (AM9) or hepatosplenic (HS) (AM3 or AM8) patients did not express Id that were inhibitory in these systems. These results suggest that a relatively high proportion of INT and HI anti-SEA antibodies express a dominant cross-reactive idiotope (CRI) recognized by 1C6/4A8. This CRI is also easily detected in plasmas from individual INT patients. Anti-Id 1C2 reacted strongly with an Id in AM1, AM5, or AM7, but one which also occurred, to a lesser extent, in AM3, AM8, and AM9. Monoclonal anti-Id 4F9 and 2A7 reacted weakly with idiotopes expressed by antibodies from all patients, regardless of the clinical form of their infection. These observations indicate that anti-SEA antibodies from INT and HI, but not acute or HS patients express dominant, CRI that are identified by 1C6, 4A8, or 1C2 and are also expressed on the INT-derived anti-SEA mAb E5.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2120345

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

Review 1.  Schistosomiasis. Infection versus disease and hypersensitivity versus immunity.

Authors:  A W Cheever
Journal:  Am J Pathol       Date:  1993-03       Impact factor: 4.307

2.  Enhanced interleukin-12 and CD40 ligand activities but reduced Staphylococcus aureus Cowan 1-induced responses suggest a generalized and progressively impaired type 1 cytokine pattern for human schistosomiasis.

Authors:  Silvia M L Montenegro; Frederico G C Abath; Ana Lúcia C Domingues; Wlademir G Melo; Clarice N L Morais; Eridan M Coutinho; Siddhartha Mahanty; Thomas A Wynn
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

3.  Two distinct pathological syndromes in male CBA/J inbred mice with chronic Schistosoma mansoni infections.

Authors:  G S Henderson; N A Nix; M A Montesano; D Gold; G L Freeman; T L McCurley; D G Colley
Journal:  Am J Pathol       Date:  1993-03       Impact factor: 4.307

4.  Polyserositis in a patient with acute paracoccidioidomycosis and hepatosplenic schistosomiasis.

Authors:  M A Shikanai-Yasuda; G Benard; M I Duarte; O H Leite; M Eira; M J Mendes-Giannini
Journal:  Mycopathologia       Date:  1995-05       Impact factor: 2.574

5.  Neonatal idiotypic exposure alters subsequent cytokine, pathology, and survival patterns in experimental Schistosoma mansoni infections.

Authors:  M A Montesano; D G Colley; S Eloi-Santos; G L Freeman; W E Secor
Journal:  J Exp Med       Date:  1999-02-15       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.